Question 1

What specific strategies will the behavior therapy involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HIV and HCV Intervention In Drug Treatment Settings - 1 clinical trial (NCT00102349). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this therapy help reduce my risk of HIV and Hepatitis C?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HIV and HCV Intervention In Drug Treatment Settings - 1 clinical trial (NCT00102349). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any side effects or risks associated with this therapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HIV and HCV Intervention In Drug Treatment Settings - 1 clinical trial (NCT00102349). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will the therapy last, and how often will I need to attend sessions?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HIV and HCV Intervention In Drug Treatment Settings - 1 clinical trial (NCT00102349). Contact the study team or your healthcare provider for specific answers.

Question 5

What other treatment options are available if this one is not suitable for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HIV and HCV Intervention In Drug Treatment Settings - 1 clinical trial (NCT00102349). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the therapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HIV and HCV Intervention In Drug Treatment Settings - 1 clinical trial (NCT00102349). Contact the study team or your healthcare provider for specific answers.

What this study is about